2014
DOI: 10.1111/pme.12249
|View full text |Cite
|
Sign up to set email alerts
|

Intradiscal Injection of Fibrin Sealant for the Treatment of Symptomatic Lumbar Internal Disc Disruption: Results of a Prospective Multicenter Pilot Study with 24-Month Follow-Up

Abstract: Intradiscal injection of BIOSTAT BIOLOGX Fibrin Sealant with the Biostat Delivery Device appears safe and may improve pain and function in selected patients with discogenic pain.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
54
0
1

Year Published

2015
2015
2022
2022

Publication Types

Select...
5
2

Relationship

0
7

Authors

Journals

citations
Cited by 43 publications
(55 citation statements)
references
References 81 publications
0
54
0
1
Order By: Relevance
“…The patients were explained about the meanings of the figures from 0 to 10 placed on a 10 cm scale. They were asked to show on the scale the numeric value that best described their pain (21,27,28,30).…”
Section: █ Materials and Methodsmentioning
confidence: 99%
See 3 more Smart Citations
“…The patients were explained about the meanings of the figures from 0 to 10 placed on a 10 cm scale. They were asked to show on the scale the numeric value that best described their pain (21,27,28,30).…”
Section: █ Materials and Methodsmentioning
confidence: 99%
“…Higher total scores indicate a higher level of disability. The maximum score is 50 points; 31-50 points was considered as severe, 11-31 as moderate and 1-10 as mild disability (1,22,27,28,30 6. Insomnia Severity Index (ISI): Developed to assess insomnia severity, this is a measurement instrument having high validity and reliability.…”
Section: █ Materials and Methodsmentioning
confidence: 99%
See 2 more Smart Citations
“…Beyond IVD allografting, the number of biomaterial‐based therapy for IVD degeneration in humans is very limited. The clinical outcomes of intradiscal injection of fibrin sealant in 15 patients with lumbar discogenic pain was reported: except for two cases of low back muscle spasm and one case of discitis, 87% of the patients achieved at least a 30% reduction in low back pain compared with the baseline at the 26‐week primary endpoint (Yin, Pauza, Olan, et al, ). In addition, a collagen sponge was selected as a carrier for bone marrow cells to treat low back pain with favourable outcomes in two cases (Yoshikawa, Ueda, Miyazaki, et al, ).…”
Section: Clinical Application Of Biomaterials For Ivd Degenerationmentioning
confidence: 99%